https://www.optometrytimes.com/view/aaopt-2026-new-dry-eye-data-perfluorohexyloctane-relief-cyclosporine-safety New research presented at the American Academy of Optometry Annual Meeting looked at two common dry eye treatments. In a real-world analysis of patients newly prescribed perfluorohexyloctane (PFHO, brand name Miebo), average symptom scores dropped meaningfully within two weeks of starting treatment and continued improving by the four-week mark. Every symptom tracked, including dryness, […]
Continue Reading... No Comments.
We have been grateful for our opportunity to help keep our planet green for seven years. To date, our patients and this office have returned to recycling over 82 POUNDS of contact lens packaging and materials! However, due to rising costs, we will be discontinuing our partnership with TerraCycle and Bausch & Lomb’s recycling program, […]
Continue Reading... No Comments.What’s New in Eye Health: Four Developments Worth Knowing About Eye care research moves quickly. Here are four recent developments, and what they mean for you and your family. Your Eyes May Offer Clues About Your Whole-Body Health A growing field called Oculomics studies what images of the eye can reveal about health elsewhere in […]
Continue Reading... Comments Off on October 2026: News you can usehttps://www.optometrytimes.com/view/aaopt-2026-demodex-worse-mgd-dry-eye-questionnaires-miss-blepharitis New research presented at the American Academy of Optometry Annual Meeting found that standard dry eye questionnaire capture only 22.4% of the symptoms of Demodex blepharitis. Demodex blepharitis is an eyelid condition caused by an overgrowth of microscopic mites that live on the eyelashes. Researchers identified common symptoms including watery eyes, itching, burning, redness, […]
Continue Reading... Comments Off on Dry Eye Questionnaires Miss Most Demodex Blepharitis Symptoms, New AAOpt 2026 Research FindsOn GLP-1 medications (Wegovy, Ozempic)?New research is looking at a possible link between these medications and a rare type of “eye stroke” (non-arteritic anterior ischemic optic neuropathy) that can cause sudden vision loss. If you’re on one of these medications and notice sudden vision changes, don’t wait — contact our office or seek emergency care […]
Continue Reading... Comments Off on Eye Health News you can use, Sept 2026 editionhttps://www.optometrytimes.com/view/arvo-2026-miyosmart-iq-demonstrates-myopia-control-in-children-as-young-as-aged-4 A new clinical trial presented at ARVO 2026 by HOYA Vision Care and The Hong Kong Polytechnic University is turning heads in myopia management. The randomized controlled trial enrolled 196 school children in Hong Kong, ages 4 to 12, and the results were striking: the new spectacle lens design halted clinically relevant myopia progression […]
Continue Reading... Comments Off on MiYOSMART iQ Halts Myopia Progression in Nearly All Young Children in Landmark Trialhttps://pratt.duke.edu/news/lab-grown-retinal-cells/ A Window into the Body There’s an old saying that the eyes are windows into the soul, and it’s more literal than you’d think, the retina connects directly to the brain, technically making your eyes part of the central nervous system. That’s part of what makes a new advance from Duke University so exciting. […]
Continue Reading... Comments Off on Lab-Grown Retinal Cells Offer New Hope for Treating Vision Losshttps://www.cedars-sinai.org/newsroom/common-bacteria-discovered-in-the-eye-linked-to-cognitive-decline Common Eye Bacteria Linked to Cognitive Decline: What Optometrists and Patients Should Know Emerging research continues to highlight the close connection between eye health and overall brain health. A recent study from Cedars-Sinai Medical Center has uncovered a potential link between a common bacterium found in the eye and cognitive decline associated with Alzheimer’s disease, offering new insight […]
Continue Reading... Comments Off on Inflammation and Eye Healthhttps://www.optometrytimes.com/view/nordic-group-bv-announces-commercial-launch-of-lacrifill-canalicular-gel Introducing Lacrifill Canalicular Gel: A Novel Dry Eye Therapy Now Commercially Available in the U.S. Nordic Group B.V., through its U.S. subsidiary Nordic Pharma, has officially launched Lacrifill® Canalicular Gel, a new interventional dry eye treatment now commercially available in the United States. This innovative therapy offers eyecare professionals a targeted approach to managing dry eye disease (DED) by […]
Continue Reading... Comments Off on New Lacrifill Canalicular Gel release for Dry Eye DiseaseIf seems to finally be warming up enough to break up a lot of the ice that’s been plaguing the metro area for the last week or so. Our hearts go out to all of our patients and friends who are still dealing with fallen trees, wrecked cars and a loss of power and internet. […]
Continue Reading... Comments Off on Weather Related Challenges